Clinical and histological characteristics of cutaneous vasculitis in SLE (n = 39)
Characteristic . | Value, n (%) . |
---|---|
Vasculitis cutaneous features | |
Palpable purpura | 21 (54) |
Urticarial lesions | 18 (46) |
Erythematous papules/macules | 12 (31) |
Ulcerated/necrotic lesions | 8 (21) |
Livedo reticularis | 5 (13) |
Nodular lesions | 1 (2.6) |
Association of lesions type | 17 (44) |
Topography of cutaneous lesions | |
Legs/lower limbs | 33 (85) |
Trunk/abdomen | 13 (33) |
Arms/upper limbs | 11 (28) |
Fingertips and/or palms | 8 (21) |
Face | 0 (0) |
Association of locations | 18 (46) |
Associated features | |
Angioedema | 3 (8) |
Episcleritis | 3 (8) |
Vasculitis visceral involvement | |
Mononeuritis multiplex | 8 (21) |
Membranoproliferative glomerulonephritis | 1 (2) |
Muscle involvement | 1 (2) |
Digestive involvement | 1 (2) |
Biological and immunological features | |
Elevated CRP level (>5 mg/l) | 20/33 (61)a |
Cryoglobulinaemiab | 15/32 (47)a |
Anti-C1q positive | 2/9 (22)a |
ANCA-positive | 0/33 (0)a |
Histological features | |
Inflammatory cell infiltration | 39 (100) |
predominant neutrophilic infiltrates | 22 (56) |
predominant lymphocytic infiltrates | 15 (38) |
predominant eosinophilic infiltrates | 0 (0) |
no predominant infiltrate | 2 (5) |
Leucocytoclasia | 33 (85) |
Vascular fibrinous necrosis | 20 (51) |
Direct Immunofluorescence features | |
Perivascular C3 deposits | 13/21 (62)a |
Perivascular Ig deposits | 8/21 (38)a |
Perivascular C1q deposits | 5/21 (24)a |
Characteristic . | Value, n (%) . |
---|---|
Vasculitis cutaneous features | |
Palpable purpura | 21 (54) |
Urticarial lesions | 18 (46) |
Erythematous papules/macules | 12 (31) |
Ulcerated/necrotic lesions | 8 (21) |
Livedo reticularis | 5 (13) |
Nodular lesions | 1 (2.6) |
Association of lesions type | 17 (44) |
Topography of cutaneous lesions | |
Legs/lower limbs | 33 (85) |
Trunk/abdomen | 13 (33) |
Arms/upper limbs | 11 (28) |
Fingertips and/or palms | 8 (21) |
Face | 0 (0) |
Association of locations | 18 (46) |
Associated features | |
Angioedema | 3 (8) |
Episcleritis | 3 (8) |
Vasculitis visceral involvement | |
Mononeuritis multiplex | 8 (21) |
Membranoproliferative glomerulonephritis | 1 (2) |
Muscle involvement | 1 (2) |
Digestive involvement | 1 (2) |
Biological and immunological features | |
Elevated CRP level (>5 mg/l) | 20/33 (61)a |
Cryoglobulinaemiab | 15/32 (47)a |
Anti-C1q positive | 2/9 (22)a |
ANCA-positive | 0/33 (0)a |
Histological features | |
Inflammatory cell infiltration | 39 (100) |
predominant neutrophilic infiltrates | 22 (56) |
predominant lymphocytic infiltrates | 15 (38) |
predominant eosinophilic infiltrates | 0 (0) |
no predominant infiltrate | 2 (5) |
Leucocytoclasia | 33 (85) |
Vascular fibrinous necrosis | 20 (51) |
Direct Immunofluorescence features | |
Perivascular C3 deposits | 13/21 (62)a |
Perivascular Ig deposits | 8/21 (38)a |
Perivascular C1q deposits | 5/21 (24)a |
Clinical and histological characteristics of cutaneous vasculitis in SLE (n = 39)
Characteristic . | Value, n (%) . |
---|---|
Vasculitis cutaneous features | |
Palpable purpura | 21 (54) |
Urticarial lesions | 18 (46) |
Erythematous papules/macules | 12 (31) |
Ulcerated/necrotic lesions | 8 (21) |
Livedo reticularis | 5 (13) |
Nodular lesions | 1 (2.6) |
Association of lesions type | 17 (44) |
Topography of cutaneous lesions | |
Legs/lower limbs | 33 (85) |
Trunk/abdomen | 13 (33) |
Arms/upper limbs | 11 (28) |
Fingertips and/or palms | 8 (21) |
Face | 0 (0) |
Association of locations | 18 (46) |
Associated features | |
Angioedema | 3 (8) |
Episcleritis | 3 (8) |
Vasculitis visceral involvement | |
Mononeuritis multiplex | 8 (21) |
Membranoproliferative glomerulonephritis | 1 (2) |
Muscle involvement | 1 (2) |
Digestive involvement | 1 (2) |
Biological and immunological features | |
Elevated CRP level (>5 mg/l) | 20/33 (61)a |
Cryoglobulinaemiab | 15/32 (47)a |
Anti-C1q positive | 2/9 (22)a |
ANCA-positive | 0/33 (0)a |
Histological features | |
Inflammatory cell infiltration | 39 (100) |
predominant neutrophilic infiltrates | 22 (56) |
predominant lymphocytic infiltrates | 15 (38) |
predominant eosinophilic infiltrates | 0 (0) |
no predominant infiltrate | 2 (5) |
Leucocytoclasia | 33 (85) |
Vascular fibrinous necrosis | 20 (51) |
Direct Immunofluorescence features | |
Perivascular C3 deposits | 13/21 (62)a |
Perivascular Ig deposits | 8/21 (38)a |
Perivascular C1q deposits | 5/21 (24)a |
Characteristic . | Value, n (%) . |
---|---|
Vasculitis cutaneous features | |
Palpable purpura | 21 (54) |
Urticarial lesions | 18 (46) |
Erythematous papules/macules | 12 (31) |
Ulcerated/necrotic lesions | 8 (21) |
Livedo reticularis | 5 (13) |
Nodular lesions | 1 (2.6) |
Association of lesions type | 17 (44) |
Topography of cutaneous lesions | |
Legs/lower limbs | 33 (85) |
Trunk/abdomen | 13 (33) |
Arms/upper limbs | 11 (28) |
Fingertips and/or palms | 8 (21) |
Face | 0 (0) |
Association of locations | 18 (46) |
Associated features | |
Angioedema | 3 (8) |
Episcleritis | 3 (8) |
Vasculitis visceral involvement | |
Mononeuritis multiplex | 8 (21) |
Membranoproliferative glomerulonephritis | 1 (2) |
Muscle involvement | 1 (2) |
Digestive involvement | 1 (2) |
Biological and immunological features | |
Elevated CRP level (>5 mg/l) | 20/33 (61)a |
Cryoglobulinaemiab | 15/32 (47)a |
Anti-C1q positive | 2/9 (22)a |
ANCA-positive | 0/33 (0)a |
Histological features | |
Inflammatory cell infiltration | 39 (100) |
predominant neutrophilic infiltrates | 22 (56) |
predominant lymphocytic infiltrates | 15 (38) |
predominant eosinophilic infiltrates | 0 (0) |
no predominant infiltrate | 2 (5) |
Leucocytoclasia | 33 (85) |
Vascular fibrinous necrosis | 20 (51) |
Direct Immunofluorescence features | |
Perivascular C3 deposits | 13/21 (62)a |
Perivascular Ig deposits | 8/21 (38)a |
Perivascular C1q deposits | 5/21 (24)a |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.